This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Aruna Balgi - Innovator in IDO Inhibitors
Introduction
Aruna Balgi is a notable inventor based in Vancouver, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of indoleamine 2,3-dioxygenase (IDO) inhibitors. Her work focuses on addressing various medical conditions through innovative therapeutic approaches.
Latest Patents
Aruna Balgi holds 1 patent related to her research on IDO inhibitors. This patent encompasses pharmaceutical compositions that contain these inhibitors and outlines their use in treating conditions characterized by pathology in the IDO-mediated tryptophan metabolic pathway. The conditions addressed include suppression of T-cell mediated immune response, cataracts, neurodegenerative disorders, mood disorders, cancer, and various bacterial and viral infections. The novel compounds developed in her research include substituted naphthalene and anthracene diones, with a specific focus on taurine-substituted naphthaquinone structures.
Career Highlights
Aruna Balgi is affiliated with the University of British Columbia, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating serious health conditions through innovative pharmaceutical solutions.
Collaborations
Aruna has collaborated with notable colleagues, including Xin-Hui Huang and Eduardo Vottero, to advance her research and explore new therapeutic avenues.
Conclusion
Aruna Balgi's contributions to the field of IDO inhibitors represent a significant advancement in pharmaceutical innovation. Her work holds promise for improving treatment options for various medical conditions, showcasing the importance of research and collaboration in the scientific community.